A new study from a research team at the Center for Wireless Communications Network and Systems (CWC-NS) at the University of ...

Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...

Over the past decade, communities across the United States have faced a steady rise in severe weather events. Climate Central ...

Morgan Stanley ( MS) is weighing reducing some of its exposure to AI data centers, having held initial discussions with potential investors about a so-called significant risk transfer ("SRT") linked ...

Analysts at Jefferies see blockbuster potential in zorevunersen in Dravet syndrome, with sales potentially reaching $1 ...

Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 trial, leading the biotech to pitch the candidate as a way to reduce reliance ...

FOX13's investigative team dug into those numbers to see the task force’s impact in neighborhoods. Our team used the ...

Data-optimized surgical preference cards based on historical supply use reduced the cost of unused items and intraoperative burden.

As AI-driven power demand accelerates, geothermal energy is quietly moving from conceptual promise toward early execution: ...

-- 80% or greater reduction in metastatic breast cancer recurrence rate over 5 years of follow-up with a peak immune response at 6 months and well-tolerated safety profile. -- The PIS elicited a ...

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced interim ...